#Coronavirus

INK Videos Oct 28, 2021
INK Ultra Money Free: BioVaxys insiders bet on the haptenization of cancer and covid
During the last week of October we put the Healthcare sector in the spotlight. On Wednesday, we ventured into the biotech space where BioVaxys (BIOV) insiders are betting big on their firm's novel approach to tackling cancer and COVID-19. Join us as a Canadian Insider or INK Research member as we let the insiders guide us to opportunity this fall.
INK Videos Oct 27, 2021
BioVaxys insiders bet on the haptenization of cancer and covid
We are continuing with our mini-series on Healthcare stocks by venturing into the biotech space. BioVaxys insiders are betting big on their firm's novel approach to tackling cancer and COVID-19.
Real Vision Mar 21, 2022
As Gas Spirals, Can Europe Divorce Russia?
We’re nearly one month into Russia’s war against Ukraine. Officials from Moscow and Kyiv have met intermittently for peace talks that have so far failed to bring a cessation of hostilities. Geopolitical tensions are once again showing up in energy markets. Several European Union member states are pushing for a fifth round of sanctions on Russia. Cutting off Russian crude would theoretically take 4% to 5% of global supply off the market. Meanwhile, Saudi Arabia, under increasing pressure to ramp up its output, is calling on Western allies to do more to help counter attacks by Iran-backed Yemeni Houthis on critical oil infrastructure. Investors are also weighing a rise in COVID-19 cases in Europe stemming from an emerging variant. Izabella Kaminska, former editor of The Financial Times’ FT Alphaville blog and founder of The Blind Spot, joins Emil Kalinowski to discuss the latest geopolitical and financial headlines, with a focus on media and propaganda surrounding the war in Eastern Europe. Want to submit questions? Drop them right here on the Exchange: https://rvtv.io/3Jww8pv
Real Vision Dec 08, 2021
Pfizer & BioNTech Share Results on Boosters as Job Openings Near All-Time High
With markets easing on Omicron fears this week and assets across the board beginning to recover from last week’s drawdowns, Pfizer and BioNTech both announced today the initial findings of the effectiveness of their boosters against the Omicron variant, demonstrating promising results of neutralizing the virus. The October JOLTS numbers also were released, showing that 4.2 million Americans quit their jobs, a decrease from the previous month, and openings increased to slightly over 11 million. 42 Macro founder and CEO Darius Dale analyzes the labor market’s recovery, COVID’s continuing impact on markets, the implications of the U.S. House passing legislation on increasing the debt ceiling limit, and more. Interviewed by Ash Bennington. Want to submit questions? Drop them right here on the Exchange: https://rvtv.io/3dAjdo6
Real Vision Feb 04, 2022
In This Great Power Conflict, China's Grand Strategy Is Clear
The best way to understand China’s posture toward the U.S. is to read President Xi Jinping’s speeches to internal audiences, not messages delivered in international settings such as Davos. That’s according to Matthew Pottinger, current Distinguished Visiting Fellow at Stanford University’s Hoover Institution and former Deputy National Security Advisor during the Trump administration. Pottinger joins Kyle Bass, founder and chief investment officer of Hayman Capital Management, for a discussion of the Middle Kingdom’s grand strategy amid a simmering “Great Power” conflict. Xi recently praised Mao Zedong for fighting a preemptive war against the United States on the Korean Peninsula, noting he was willing to destroy his own nation in order to begin anew. Xi, according to Pottinger, is serious about “throwing one punch” to wreck capitalism and topple western-style democracy. In addition to shedding some light on China’s response to COVID-19, Pottinger offers his thoughts on how the U.S. can counter China’s global ambitions.
INK Videos Nov 29, 2021
Crew charts a course in BC
With oil & gas shares taking it on the chin on Friday, it is a good time to revisit the Energy sector and our best-performing morning report stock year-to-date, Crew Energy (CR).